Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.1 USD | +0.74% |
|
+2.60% | -15.54% |
07-11 | Piper Sandler Trims Price Target on Perrigo to $35 From $36, Maintains Overweight Rating | MT |
07-10 | Perrigo Divests HRA Pharma Rare Diseases Business to Esteve Healthcare | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.54% | 3.67B | |
+62.83% | 856B | |
+38.95% | 631B | |
-4.07% | 359B | |
+15.83% | 325B | |
+8.67% | 297B | |
+5.89% | 234B | |
+16.53% | 226B | |
+15.63% | 177B | |
+1.82% | 165B |
- Stock Market
- Equities
- PRGO Stock
- News Perrigo Company plc
- Transcript : Perrigo Company plc Presents at 35th Annual JP Morgan Healthcare Conference, Jan-10-2017 08